Inflammatory marker profiles vary by BMI across Crohn’s disease, ulcerative colitis, psoriasis, and psoriatic arthritis - Top-Institutions - MDSpire

Profiles of Inflammatory Markers Differ by Body Mass Index in Crohn’s Disease, Ulcerative Colitis, Psoriasis, and Psoriatic Arthritis

  • By

  • Stephen A. Shields

  • Ann Von Holle

  • Ruthvik Padival

  • Joseph F. Merola

  • Rachael Zuckerman

  • Jeff T. Mohl

  • Elizabeth L. Ciemins

  • July 17, 2026

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Hospital/Johns Hopkins Medicine
    Johns Hopkins Hospital/Johns Hopkins Medicine

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Rheumatology

Original Source(s)

Inflammatory marker profiles vary by BMI across Crohn’s disease, ulcerative colitis, psoriasis, and psoriatic arthritis

  • by Stephen A. Shields, Ann Von Holle, Ruthvik Padival, Joseph F. Merola, Rachael Zuckerman, Jeff T. Mohl, Elizabeth L. Ciemins

  • July 17, 2026

Related Content

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity

Efficacy Comparison of Cycling Versus Transitioning to IL-17 Inhibitors Following Initial TNF Inhibitor Failure in Psoriatic Arthritis: A Multicenter Real-World Analysis

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.